Author Login

• Research Article
• Open Access
• Dr. Arturo Solis Herrera

Carbonic anhydrase (CA) is a zinc metalloenzyme widely distributed throughout the tissues of the body. In the kidney, this enzyme is thought to play a pivotal role in urinary acidification and bicarbonate reabsorption.

• Research Article
• Open Access
• Dr. Sanjay P Dhangar,

A severe kidney infection associated to gas production in the renal parenchyma and/or collecting system is known as emphysematous pyelonephritis.

• Research Article
• Open Access
• Joanna Kabat-Koperska

Kidney transplantation remains the treatment of choice in end-stage kidney disease. The introduction of new immunosuppressive drugs has significantly extended

• Research Article
• Open Access
• Subodh J. Saggi

Peritonitis remains the most feared complication of End Stage Renal Disease (ESRD) patients on peritoneal dialysis (PD), but cultures are often negative.

• Editorial
• Open Access
• Yi-Hong K. Piccoli

About 10% of adults worldwide suffer from chronic kidney disease, which is among the top 20 causes of death globally and can have a devastating effect on patients and their families.

• Review Article
• Open Access
• Siovanni A. Mornacchia

A deeper knowledge of disease has been made possible by transcrip tomics, and the sequencing of individual genes is emerging as a primary method for finding new germ lines. Key marker gene expression that distinguishes principle cells (PC) and intercalated cells (IC) was used to characterise a recently identified cell type known as transitional cells.

• Case Report
• Open Access
• Dirtipal R. Patel

After kidney transplant surgery, vascular problems are incredibly rare; the incidence of pseudoaneurysm is even lower, at 0.3%. The symptoms might range from sudden, severe bleeding to long-term, dull, throbbing pain, anorexia, etc.

• Review Article
• Open Access
• Xiao Li

It has been discovered that fibroblast growth factor-23 (FGF-23) is a pathogenic factor and circulating hormone in a variety of medical diseases. Recent developments in FGF-23 as a therapeutic target are reviewed in this study, including FGF-23 antagonist, FGF-23 antibody, FGF-23 C-terminal peptide, CYP24A1 inhibitor, and fibroblast growth factor receptors (FGFR) tyrosine kinase inhibitor.

• Case Report
• Open Access
• Jharles Warkulis

Here, we present the first instance of severe, symptomatic hypercalcemia that has been documented after the use of surgically implanted calcium-based beads into a hip replacement For the purpose of publication, the patient’s agreement has been sought for the clinical history and x-rays.